Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,025.02
2,171.37
2,147.71
1,938.26
1,722.61
1,549.87
1,622.66
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,025.02
2,171.37
2,147.71
1,938.26
1,722.61
1,549.87
1,622.66
Raw Material Cost
532.38
621.08
633.37
620.98
482.62
480.00
481.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
374.51
400.36
454.08
498.12
371.15
320.19
291.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.08
14.09
16.70
20.58
18.98
11.69
5.77
Selling and Distribution Expenses
821.55
880.74
896.46
787.74
706.04
600.94
599.14
Other Expenses
-25.74
-26.22
-33.55
-32.50
-20.67
-19.04
-20.58
Total Expenditure (Excl Depreciation)
1,491.08
1,654.11
1,665.14
1,602.40
1,372.10
1,222.38
1,172.46
Operating Profit (PBDIT) excl Other Income
533.9
517.3
482.59999999999997
335.90000000000003
350.5
327.5
450.20000000000005
Other Income
43.98
175.04
74.76
150.92
127.68
46.01
57.44
Operating Profit (PBDIT)
659.97
781.72
659.57
590.61
567.03
441.90
588.01
Interest
20.08
14.09
16.70
20.58
18.98
11.69
5.77
Exceptional Items
7.71
4.75
1.28
0.18
-6.01
1.34
-1.03
Gross Profit (PBDT)
1,492.64
1,550.29
1,514.34
1,317.28
1,240.00
1,069.87
1,141.07
Depreciation
107.84
126.48
124.73
124.04
112.99
82.38
92.54
Profit Before Tax
539.76
645.89
519.42
446.18
429.05
349.16
488.67
Tax
103.79
122.40
96.99
116.65
85.34
67.14
75.49
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
433.13
521.53
421.30
329.53
343.72
277.02
392.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
433.13
521.53
421.30
329.53
343.72
277.02
392.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
433.13
521.53
421.30
329.53
343.72
277.02
392.14
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,191.04
3,009.78
2,816.96
2,813.33
2,839.82
2,959.00
2,815.44
Earnings per share (EPS)
0.74
0.89
0.72
0.56
0.6
0.48
0.67
Diluted Earnings per share
0.74
0.89
0.72
0.56
0.6
0.48
0.67
Operating Profit Margin (Excl OI)
25.09%
22.12%
21.42%
16.29%
18.95%
20.23%
26.99%
Gross Profit Margin
31.98%
35.57%
29.99%
29.42%
31.47%
27.84%
35.82%
PAT Margin
21.39%
24.02%
19.62%
17.0%
19.95%
17.87%
24.17%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -6.74% vs 1.10% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -16.95% vs 23.78% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 1.53% vs 3.74% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 42.55% vs -15.57% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Guilin Sanjin Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,025.02
0
2,025.02
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,025.02
0
2,025.02
Raw Material Cost
532.38
0
532.38
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
374.51
0
374.51
Power Cost
0
0
0.00
Manufacturing Expenses
20.08
0
20.08
Selling and Distribution Expenses
821.55
0
821.55
Other Expenses
-25.74
0.00
-25.74
Total Expenditure (Excl Depreciation)
1,491.08
0
1,491.08
Operating Profit (PBDIT) excl Other Income
533.94
0.00
533.94
Other Income
43.98
0
43.98
Operating Profit (PBDIT)
659.97
0
659.97
Interest
20.08
0
20.08
Exceptional Items
7.71
0
7.71
Gross Profit (PBDT)
1,492.64
0
1,492.64
Depreciation
107.84
0
107.84
Profit Before Tax
539.76
0
539.76
Tax
103.79
0
103.79
Provisions and contingencies
0
0
0.00
Profit After Tax
433.13
0
433.13
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
433.13
0
433.13
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
433.13
0
433.13
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,191.04
0
3,191.04
Earnings per share (EPS)
0.74
0
0.74
Diluted Earnings per share
0.74
0
0.74
Operating Profit Margin (Excl OI)
25.09%
0%
0.00
25.09%
Gross Profit Margin
31.98%
0%
0.00
31.98%
PAT Margin
21.39%
0%
0.00
21.39%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 202.50 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -6.74% vs 1.10% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 43.31 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -16.95% vs 23.78% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 61.60 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1.53% vs 3.74% in Dec 2024
Annual - Interest
Interest 2.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 42.55% vs -15.57% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.09%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






